Clinical trial
Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis
NCT00004300 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Suspended
Key facts
| NCT number | NCT00004300 |
|---|---|
| Title | Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis |
| Official title | Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Collaborators | University of Florida |
| Status | Suspended |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stereotyped Behavior, Mental Retardation |
| Intervention type | Drug |
| Interventions | bromocriptine, sertraline hydrochloride |
| Enrollment | 40 |
| First posted | Oct 19, 1999 |
| Last update posted | Oct 6, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: